Intra-Cellular Therapies
ITCI
#1799
Rank
$9.14 B
Marketcap
$86.27
Share price
-0.31%
Change (1 day)
56.88%
Change (1 year)

EPS for Intra-Cellular Therapies (ITCI)

EPS in 2023 (TTM): -$1.61

According to Intra-Cellular Therapies's latest financial reports the company's current EPS (TTM) is -$1.61. In 2022 the company made an earnings per share (EPS) of -$2.72 an increase over its 2021 EPS that were of -$3.50.

EPS history for Intra-Cellular Therapies from 2014 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.61-40.81%
2022-$2.72-22.29%
2021-$3.508.02%
2020-$3.2420.9%
2019-$2.68-5.63%
2018-$2.8433.96%
2017-$2.12-21.19%
2016-$2.69-7.56%
2015-$2.91174.53%
2014-$1.06

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$0.25-84.47%๐Ÿ‡บ๐Ÿ‡ธ USA
-$10.00 521.12%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.14 32.92%๐Ÿ‡บ๐Ÿ‡ธ USA